C-REACTIVE PROTEIN LEVELS AND THE SEVERITY OF COVID-19
Objective: To compare the C-reactive proteinlevels in different groups of COVID-19 patients to assess disease severity. Study Design: Cross sectional study. Place and Duration of Study: Combined Military Hospital Kohat, from Apr 2020 to Jun2020. Methodology: Forty fiveConfirmed cases of COV...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Army Medical College Rawalpindi
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/50dfd564b9904270a92926c9d0b2ebad |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:50dfd564b9904270a92926c9d0b2ebad |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:50dfd564b9904270a92926c9d0b2ebad2021-12-02T17:41:46ZC-REACTIVE PROTEIN LEVELS AND THE SEVERITY OF COVID-190030-96482411-8842https://doaj.org/article/50dfd564b9904270a92926c9d0b2ebad2020-09-01T00:00:00Zhttps://pafmj.org/index.php/PAFMJ/article/view/5320https://doaj.org/toc/0030-9648https://doaj.org/toc/2411-8842Objective: To compare the C-reactive proteinlevels in different groups of COVID-19 patients to assess disease severity. Study Design: Cross sectional study. Place and Duration of Study: Combined Military Hospital Kohat, from Apr 2020 to Jun2020. Methodology: Forty fiveConfirmed cases of COVID-19 patients were included by non-probability consecutive sampling. Patients were divided into five groups (Asymptomatic, Mild, Moderate, Severe and Critical). Serum sample for C -reactiveprotein levels were collected at presentation and compared in different clinical groups by Paired sample “t” test andoneway Anova(Post Hoc LSD). Result: Out of 45 cases in our study28 (62.2%) were male and 17 (37.8%) were female. Mean age of patients was 51.96 ± 16 and mean C-reactiveproteinlevels were 76.61± 75 mg/L. When compared by paired sample t-test C-reactive proteinlevels were: higherin the mild patient group than asymptomatic group, higher inthe moderate groupthan mild group, higherin severe group than moderate group and those in the critical group were higherthan those in the severe group. The difference was statistically significant with p-value <0.05 in each group. Conclusion: C-reactive proteinlevelswerelowest in asymptomatic and highest in critical patients inearly COVID-19. This may help guide management.Mirza Waseem JavedMuhammad AnwarTariq Mehmood BangashRizwan Ul Haq SattiMehar RehmanUzair Ijaz MalikArmy Medical College Rawalpindiarticlecovid-19c-reactive proteindisease severity classificationMedicineRMedicine (General)R5-920ENPakistan Armed Forces Medical Journal, Vol 70, Iss 2, Pp 603-607 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
covid-19 c-reactive protein disease severity classification Medicine R Medicine (General) R5-920 |
spellingShingle |
covid-19 c-reactive protein disease severity classification Medicine R Medicine (General) R5-920 Mirza Waseem Javed Muhammad Anwar Tariq Mehmood Bangash Rizwan Ul Haq Satti Mehar Rehman Uzair Ijaz Malik C-REACTIVE PROTEIN LEVELS AND THE SEVERITY OF COVID-19 |
description |
Objective: To compare the C-reactive proteinlevels in different groups of COVID-19 patients to assess disease severity.
Study Design: Cross sectional study.
Place and Duration of Study: Combined Military Hospital Kohat, from Apr 2020 to Jun2020.
Methodology: Forty fiveConfirmed cases of COVID-19 patients were included by non-probability consecutive sampling. Patients were divided into five groups (Asymptomatic, Mild, Moderate, Severe and Critical). Serum sample for C -reactiveprotein levels were collected at presentation and compared in different clinical groups by Paired sample “t” test andoneway Anova(Post Hoc LSD).
Result: Out of 45 cases in our study28 (62.2%) were male and 17 (37.8%) were female. Mean age of patients was 51.96 ± 16 and mean C-reactiveproteinlevels were 76.61± 75 mg/L. When compared by paired sample t-test C-reactive proteinlevels were: higherin the mild patient group than asymptomatic group, higher inthe moderate groupthan mild group, higherin severe group than moderate group and those in the critical group were higherthan those in the severe group. The difference was statistically significant with p-value <0.05 in each group.
Conclusion: C-reactive proteinlevelswerelowest in asymptomatic and highest in critical patients inearly COVID-19. This may help guide management. |
format |
article |
author |
Mirza Waseem Javed Muhammad Anwar Tariq Mehmood Bangash Rizwan Ul Haq Satti Mehar Rehman Uzair Ijaz Malik |
author_facet |
Mirza Waseem Javed Muhammad Anwar Tariq Mehmood Bangash Rizwan Ul Haq Satti Mehar Rehman Uzair Ijaz Malik |
author_sort |
Mirza Waseem Javed |
title |
C-REACTIVE PROTEIN LEVELS AND THE SEVERITY OF COVID-19 |
title_short |
C-REACTIVE PROTEIN LEVELS AND THE SEVERITY OF COVID-19 |
title_full |
C-REACTIVE PROTEIN LEVELS AND THE SEVERITY OF COVID-19 |
title_fullStr |
C-REACTIVE PROTEIN LEVELS AND THE SEVERITY OF COVID-19 |
title_full_unstemmed |
C-REACTIVE PROTEIN LEVELS AND THE SEVERITY OF COVID-19 |
title_sort |
c-reactive protein levels and the severity of covid-19 |
publisher |
Army Medical College Rawalpindi |
publishDate |
2020 |
url |
https://doaj.org/article/50dfd564b9904270a92926c9d0b2ebad |
work_keys_str_mv |
AT mirzawaseemjaved creactiveproteinlevelsandtheseverityofcovid19 AT muhammadanwar creactiveproteinlevelsandtheseverityofcovid19 AT tariqmehmoodbangash creactiveproteinlevelsandtheseverityofcovid19 AT rizwanulhaqsatti creactiveproteinlevelsandtheseverityofcovid19 AT meharrehman creactiveproteinlevelsandtheseverityofcovid19 AT uzairijazmalik creactiveproteinlevelsandtheseverityofcovid19 |
_version_ |
1718379644079570944 |